{"id":"https://openalex.org/W2410288657","doi":null,"title":"Natalizumab-Associated Progressive Multifocal Leukoencephalopathy","display_name":"Natalizumab-Associated Progressive Multifocal Leukoencephalopathy","publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W2410288657","mag":"2410288657"},"language":"en","primary_location":{"id":"mag:2410288657","doi":null,"is_oa":false,"landing_page_url":"https://www.nejm.org/doi/pdf/10.1056/NEJMc1207116","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100767595","display_name":"Fernando J. Mart\u00ednez","orcid":"https://orcid.org/0000-0002-2412-3182","observed_orcids":["https://orcid.org/0000-0002-2412-3182","https://orcid.org/0000-0003-4957-8869","https://orcid.org/0000-0001-8298-2703"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fernando J. Mart\u00ednez","raw_affiliation_strings":["\u2020University of Michigan"],"raw_orcid":"https://orcid.org/0000-0002-2412-3182","affiliations":[{"raw_affiliation_string":"\u2020University of Michigan","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021656163","display_name":"Ganesh Raghu","orcid":"https://orcid.org/0000-0001-7506-6643","observed_orcids":["https://orcid.org/0000-0001-7506-6643","https://orcid.org/0000-0001-8746-3507"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ganesh Raghu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7506-6643","affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.31595092,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11827","display_name":"Polyomavirus and related diseases","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11827","display_name":"Polyomavirus and related diseases","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10981","display_name":"Cytomegalovirus and herpesvirus research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/natalizumab","display_name":"natalizumab","score":0.9929999709129333},{"id":"https://openalex.org/keywords/progressive-multifocal-leukoencephalopathy","display_name":"progressive multifocal leukoencephalopathy","score":0.9990000128746033},{"id":"https://openalex.org/keywords/jc-virus","display_name":"JC virus","score":0.9779999852180481},{"id":"https://openalex.org/keywords/treatment-duration","display_name":"treatment duration","score":0.7620000243186951},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.6980000138282776},{"id":"https://openalex.org/keywords/cell-mediated-immunity","display_name":"cell-mediated immunity","score":0.6520000100135803},{"id":"https://openalex.org/keywords/risk-stratification","display_name":"risk stratification","score":0.546999990940094},{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.7070000171661377}],"concepts":[{"id":"https://openalex.org/C2781004633","wikidata":"https://www.wikidata.org/wiki/Q386119","display_name":"Natalizumab","level":3,"score":0.992378294467926},{"id":"https://openalex.org/C2780644213","wikidata":"https://www.wikidata.org/wiki/Q704930","display_name":"Progressive multifocal leukoencephalopathy","level":3,"score":0.9773455858230591},{"id":"https://openalex.org/C2779150272","wikidata":"https://www.wikidata.org/wiki/Q1676563","display_name":"JC virus","level":4,"score":0.9025890827178955},{"id":"https://openalex.org/C2776535787","wikidata":"https://www.wikidata.org/wiki/Q1084257","display_name":"Serostatus","level":4,"score":0.7763925790786743},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7358561754226685},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.4944007396697998},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.48063865303993225},{"id":"https://openalex.org/C2778583010","wikidata":"https://www.wikidata.org/wiki/Q3237081","display_name":"Leukoencephalopathy","level":3,"score":0.47669050097465515},{"id":"https://openalex.org/C2776036978","wikidata":"https://www.wikidata.org/wiki/Q425137","display_name":"Fingolimod","level":3,"score":0.4558412730693817},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3767588436603546},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36860257387161255},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.36032044887542725},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3439478874206543},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.18253907561302185},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.1726633608341217}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2410288657","doi":null,"is_oa":false,"landing_page_url":"https://www.nejm.org/doi/pdf/10.1056/NEJMc1207116","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W1553702798","https://openalex.org/W1969355897","https://openalex.org/W1983511886","https://openalex.org/W2008732326","https://openalex.org/W2105391426","https://openalex.org/W2109784161","https://openalex.org/W2140463009"],"related_works":["https://openalex.org/W2044022462","https://openalex.org/W2046264438","https://openalex.org/W2329140294","https://openalex.org/W2589921973","https://openalex.org/W2151575412","https://openalex.org/W2589291013","https://openalex.org/W2314996545","https://openalex.org/W2315552867","https://openalex.org/W2335147991","https://openalex.org/W2060597477"],"abstract_inverted_index":{"To":[0],"the":[1,10,31,43,81,86,97,109,112,147,151,164],"Editor:":[2],"Bloomgren":[3],"and":[4,30,183,223,227],"colleagues":[5],"(May":[6],"17":[7],"issue)1":[8],"stratify":[9],"risk":[11,37,117,132,166],"of":[12,28,33,38,57,64,68,71,85,99,111,119,137,144,150,157,167,170,190,200,210,239],"natalizumab-associated":[13],"progressive":[14],"multifocal":[15],"leukoencephalopathy":[16],"(PML)":[17],"using":[18],"JC":[19,58,72,87,113,180],"virus":[20,59,88,181],"serostatus,":[21],"status":[22,138],"with":[23,139],"respect":[24,140],"to":[25,47,49,78,108,125,141,197,202,242],"previous":[26,142,188],"use":[27,143,189],"immunosuppressants,":[29],"duration":[32],"natalizumab":[34,126],"treatment.":[35],"The":[36,115],"PML":[39,120,171],"increases":[40],"abruptly":[41],"when":[42],"treatment":[44],"is":[45],"prolonged":[46,123],"61":[48],"72":[50],"months.":[51],"Natalizumab-exposed":[52],"patients":[53,174],"have":[54,185],"higher":[55],"degrees":[56],"replication":[60],"after":[61,195],"12":[62],"months":[63,156,199],"treatment,":[65,158],"mainly":[66],"because":[67],"a":[69,131],"deterioration":[70],"virus\u2013specific":[73],"cellular":[74],"immune":[75],"responses,2":[76],"leading":[77],"rearrangements":[79],"in":[80,96,102],"regulatory":[82],"genomic":[83],"region":[84],"that":[89,122,163],"generates":[90],"this":[91,243],"neurotropic":[92],"virus.3":[93],"A":[94],"reduction":[95],"retention":[98],"B":[100],"cells":[101],"secondary":[103],"lymph":[104],"tissues":[105],"may":[106,192],"contribute":[107],"dissemination":[110],"virus.4":[114],"dichotomous":[116],"pattern":[118],"suggests":[121],"exposure":[124,201],"(>48":[127],"months)":[128],"can":[129],"be":[130,161],"factor":[133],"for":[134,178],"PML,":[135],"regardless":[136],"immunosuppressants.":[145],"Although":[146],"end":[148],"point":[149],"estimates":[152],"was":[153,245],"at":[154],"48":[155,198],"it":[159],"must":[160],"noted":[162],"estimated":[165],"4.6":[168],"cases":[169],"per":[172],"1000":[173],"who":[175,184],"are":[176],"positive":[177],"anti\u2013":[179],"antibodies":[182],"had":[186],"no":[187],"immunosuppressants":[191],"dramatically":[193],"increase":[194],"25":[196],"natalizumab.":[203],"Carlos":[204],"Cervera,":[205],"M.D.,":[206],"Ph.D.":[207],"Hospital":[208],"Clinic":[209],"Barcelona":[211],"Barcelona,":[212],"Spain":[213],"ccervera@clinic.ub.es":[214],"Dr.":[215],"Cervera":[216],"reports":[217],"receiving":[218],"grant":[219],"support,":[220,222],"travel":[221],"lecture":[224],"fees":[225],"from,":[226],"serving":[228],"as":[229],"an":[230],"advisory-board":[231],"member":[232],"for,":[233],"Novartis.":[234],"No":[235],"other":[236],"potential":[237],"conflict":[238],"interest":[240],"relevant":[241],"letter":[244],"reported.":[246]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2016-06-24T00:00:00"}